Plasma Metabolomics Profiling of Metabolic Pathways Affected by Major Depressive Disorder
Background: Major depressive disorder (MDD) is a common disease which is complicated by metabolic disorder. Although MDD has been studied relatively intensively, its metabolism is yet to be elucidated.Methods: To profile the global pathophysiological processes of MDD patients, we used metabolomics t...
Main Authors: | Yue Du, Jinxue Wei, Zijian Zhang, Xiao Yang, Min Wang, Yu Wang, Xiongwei Qi, Liansheng Zhao, Yang Tian, Wanjun Guo, Qiang Wang, Wei Deng, Minli Li, Dongtao Lin, Tao Li, Xiaohong Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2021.644555/full |
Similar Items
-
Decreased plasma neuropeptides in first-episode schizophrenia, bipolar disorder, major depressive disorder: associations with clinical symptoms and cognitive function
by: Hua Yu, et al.
Published: (2023-05-01) -
Serine and glycine metabolism-related gene expression signature stratifies immune profiles of brain gliomas, and predicts prognosis and responses to immunotherapy
by: Siliang Chen, et al.
Published: (2022-11-01) -
Identifying transdiagnostic biological subtypes across schizophrenia, bipolar disorder, and major depressive disorder based on lipidomics profiles
by: Shiwan Tao, et al.
Published: (2022-09-01) -
A Whole Transcriptome Analysis in Peripheral Blood Suggests That Energy Metabolism and Inflammation Are Involved in Major Depressive Disorder
by: Yu Wang, et al.
Published: (2022-05-01) -
Metformin Is a Pyridoxal-5′-phosphate (PLP)-Competitive Inhibitor of SHMT2
by: Angela Tramonti, et al.
Published: (2021-08-01)